Hypertension: management perspectives (Q38026885)

27 August 2017

title

Hypertension: management perspectives (English)

1 reference

27 August 2017

Claudio Borghi

1 reference

27 August 2017

Arrigo F G Cicero

series ordinal

1 reference

27 August 2017

language of work or name

English

0 references

publication date

18 July 2012

1 reference

Expert Opinion on Pharmacotherapy

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

1999-2003

1 reference

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Reducing cardiovascular events and end-organ damage in patients with hypertension: new considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Vaccination against high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

A prospective study of plasma lipid levels and hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Dyslipidemia and the risk of incident hypertension in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Expert consensus document on arterial stiffness: methodological issues and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Endothelin antagonism in patients with resistant hypertension and hypertension nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.708733

10.1517/14656566.2012.708733

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference